Health Affairs, 28, no. 5 (2009): 1549-1550 doi: 10.1377/hlthaff.28.5.1549 © 2009 by Project HOPE	New Online   Senate Health Reform Bill   Rewarding Providers   Public Option Policy Brief   Health Reform & Abortion   Delivery System Reform

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Google Scholar Articles by Busch, S. H. PubMed Articles by Busch, S. H.

Book Reviews

Medication Treatment For ADHD: Controversy Abounds

The first 100 words of the full text of this article appear below.

Between 1987 and 1996 the use of medication treatments for pediatric attention deficit hyperactivity disorder (ADHD) increased fourfold, from 0.6 percent to 2.4 percent. Treatment rates have since plateaued, but stimulants are still the most-prescribed psychotropic drug for children.¹ Although theories regarding the cause of these increases abound, what has not surfaced is a clear consensus on whether increases in the diagnosis and treatment of childhood ADHD indicate success in reducing the symptoms of an important disabling disorder, leading to improved outcomes for sick children, or society’s failing of America’s youth.

In Medicating Children, Rick Mayes and coauthors summarize the . . . [Full Text of this Article]

Susan H. Busch

                      What's this?